Product Review

Product News: 04 2014

Cutis. 2014 April;93(4):214

This month's featured products include Revision Skincare's Anti-Redness Essentials kit that incorporates 5 products to calm, hydrate, and protect the skin while providing antiaging benefits. Pierre Fabre Dermatologie obtains marketing authorization for the pediatric drug Hemangeol for proliferating infantile hemangioma requiring systemic therapy. Paladin Labs Inc receives US Food and Drug Administration approval of Impavido for leishmaniasis. Celgene Corporation receives approval for Otezla to treat adults with active psoriatic arthritis. Obagi Medical Products, Inc, a division of Valeant Pharmaceuticals North America LLC, adds 2 products to the Professional-C line. Pierre Fabre Dermo-Cosmétique USA introduces the Avène SOS Non-Ablative Post-Procedure Recovery Kit created for patients who have undergone nonablative laser, nonablative peel, or laser hair removal treatments. Xolair is approved for a new indication for the treatment of chronic idiopathic urticaria.
Read the Full Article

 

Recommended Reading

Giant Cell Tumor of the Tendon Sheath
MDedge Dermatology
What Is Your Diagnosis? Subacute Cutaneous Lupus Erythematosus
MDedge Dermatology
Is the Sunshine Act Worthy of Concern?
MDedge Dermatology
Cutaneous Manifestations of Injectable Drug Use: Hidden Secrets
MDedge Dermatology
Pulsed Dye Laser for the Treatment of Macular Amyloidosis: A Case Report
MDedge Dermatology
Palmoplantar Keratoderma With Progressive Gingivitis and Recurrent Pyodermas
MDedge Dermatology
Familial Confluent and Reticulate Papillomatosis Successfully Treated With Minocycline
MDedge Dermatology
Primary Cutaneous Candida tropicalis Infection in a Patient With B-Cell Lymphoma
MDedge Dermatology
A Cohort Study on a Ceramide-Containing Cleanser and Moisturizer Used for Atopic Dermatitis
MDedge Dermatology
Increased Risk for Melanoma in Men With Prostate Cancer: Implications for Clinical Practice?
MDedge Dermatology